1. Assume that for digoxin, the therapeutic range is cited as Cavg 5.5 = 0.8 - 2 mg/ml. If the patient is assumed to have an estimated digoxin t1/2 of 48 hours, how long would you wait to take serum digoxin concentration measurement and when during the dosing interval would you schedule it? 
(a) 28 days then 3-4 hours after the dose is administered 
(b) 14 days then 6-8 hours after the dose is administered 
(c) 7 days then 10-14 hours after the dose is administered 
(d) 3 days then 1-2 hours after the dose is administered 

1. Separation of a tablet into two or more distinct layers is called as
(a) Capping
(b) Mottling
(c) Chipping
(d) Lamination
Correct Answer : (a) Capping

2. The polyethylene glycol ointment is an example of which type of ointment base?
(a) Hydrocarbon base
(b) Absorption base
(c) Cream base
(d) Water-soluble base
Correct Answer : (a) Hydrocarbon base

3. In the production facility of injectable drug products, the water for injection is stored in tanks at
(a) 10°C
(b) 37°C
(c) 50°C
(d) 80°C Correct Answer : (b) 37°C

Researchers from Ruhr University Bochum, Germany, have uncovered new evidence showing that the hepatitis E virus (HEV) begins evolving much earlier during infection than previously understood. The findings, published in the journal mBio, reveal that although the virus exhibits relatively low genetic diversity during the acute phase, it rapidly acquires specific recurring mutations within just a few weeks of infection. The discovery offers new insights into how HEV adapts inside the human body and could help guide future antiviral research.

Emcure Pharmaceuticals Limited has announced a major strategic restructuring of its biopharmaceutical business by acquiring the remaining 12.05% minority stake in Gennova Biopharmaceuticals Limited, making it a wholly owned subsidiary. The company also announced a leadership transition, appointing Samit Mehta to lead Gennova as it sharpens its focus on biologics, biosimilars, and next-generation therapeutic platforms.

In a significant move to strengthen the regulation of certain medicinal products, the Ministry of Health and Family Welfare has notified the Drugs (Tenth Amendment) Rules, 2026, bringing specific high-alcohol oral formulations under the stricter provisions of Schedule H1 of the Drugs Rules, 1945.